22,23-dihydrobrassicasterol

22,23-dihydrobrassicasterol is a lipid of Sterol Lipids (ST) class. 22,23-dihydrobrassicasterol is associated with abnormalities such as Diabetes, Macular degeneration, Drusen, Systemic disease and Diabetes Mellitus. The involved functions are known as cholesterol metabolism, Synthesis, Intestinal Absorption, Liver function and cholesterol absorption. 22,23-dihydrobrassicasterol often locates in Back and Cell membrane. The associated genes with 22,23-dihydrobrassicasterol are apolipoprotein E-3. The related lipids are Total cholesterol, campesterol, lathosterol, Fatty Acids, Nonesterified and Cholesterol, Dietary.

Cross Reference

Introduction

To understand associated biological information of 22,23-dihydrobrassicasterol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 22,23-dihydrobrassicasterol?

22,23-dihydrobrassicasterol is suspected in Diabetes, Macular degeneration, Drusen, Systemic disease, Diabetes Mellitus, Liver diseases and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 22,23-dihydrobrassicasterol

MeSH term MeSH ID Detail
Coronary Disease D003327 70 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Hyperlipoproteinemia Type II D006938 22 associated lipids
Hyperlipidemias D006949 73 associated lipids
Hypolipoproteinemias D007009 9 associated lipids
Xanthomatosis D014973 17 associated lipids
Metabolic Syndrome D024821 44 associated lipids
Total 7

PubChem Associated disorders and diseases

What pathways are associated with 22,23-dihydrobrassicasterol

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 22,23-dihydrobrassicasterol?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 22,23-dihydrobrassicasterol?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 22,23-dihydrobrassicasterol?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with 22,23-dihydrobrassicasterol?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 22,23-dihydrobrassicasterol?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 22,23-dihydrobrassicasterol

Download all related citations
Per page 10 20 50 100 | Total 313
Authors Title Published Journal PubMed Link
Takahashi K et al. Metabolic conversion of 24-methyl-Delta25-cholesterol to 24-methylcholesterol in higher plants. 2006 Bioorg. Med. Chem. pmid:16213729
Ikeda I et al. Campest-5-en-3-one, an oxidized derivative of campesterol, activates PPARalpha, promotes energy consumption and reduces visceral fat deposition in rats. 2006 Biochim. Biophys. Acta pmid:16616424
Gerloff T et al. Influence of the SLCO1B1*1b and *5 haplotypes on pravastatin's cholesterol lowering capabilities and basal sterol serum levels. 2006 Naunyn Schmiedebergs Arch. Pharmacol. pmid:16568260
Hedman M et al. Serum noncholesterol sterols in children with heterozygous familial hypercholesterolemia undergoing pravastatin therapy. 2006 J. Pediatr. pmid:16492436
Takahashi K et al. Purification and ATPase activity of human ABCA1. 2006 J. Biol. Chem. pmid:16500904
de Jong A et al. Plant sterol or stanol consumption does not affect erythrocyte osmotic fragility in patients on statin treatment. 2006 Eur J Clin Nutr pmid:16482072
Sorenson WR and Sullivan D Determination of campesterol, stigmasterol, and beta-sitosterol in saw palmetto raw materials and dietary supplements by gas chromatography: single-laboratory validation. 2006 Jan-Feb J AOAC Int pmid:16512224
Ryan E et al. Fatty acid profile, tocopherol, squalene and phytosterol content of brazil, pecan, pine, pistachio and cashew nuts. 2006 May-Jun Int J Food Sci Nutr pmid:17127473
Fransen HP et al. Customary use of plant sterol and plant stanol enriched margarine is associated with changes in serum plant sterol and stanol concentrations in humans. 2007 J. Nutr. pmid:17449596
Hansel B et al. Effect of low-fat, fermented milk enriched with plant sterols on serum lipid profile and oxidative stress in moderate hypercholesterolemia. 2007 Am. J. Clin. Nutr. pmid:17823447